Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01921400 · ClinicalTrials.gov registry record
The Pathogenesis of Hepatitis C Virus Vertical Transmission
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 38
- Enrollment target
NCT01921400 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 38 participants.
The verdict
NCT01921400 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
To evaluate for the presence of HCV Core protein, HCV RNA and SPP in the placenta and fetal membranes using paraffin-embedded sections and post-delivery specimens respectively. In parallel, we will assess placental tissue for evidence of HCV infection using a novel in situ hybridization technique and translate our in vitro findings to these in vivo samples. Our overall hypothesis is that cytotrophoblasts at the maternal-fetal interface within the placenta serve as a "barrier" that must be crossed during vertical transmission and that cytotrophoblasts are permissive to HCV at a low level that may be enhanced under certain conditions. By comparing the regulation of key steps in the intracellular life cycle of HCV in cytotrophoblasts to highly permissive hepatocytes, significant differences in HCV regulation should be revealed. Based on our preliminary data, our working hypothesis is that HCV Core protein is differentially processed in cytotrophoblasts compared to hepatocytes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2013-01 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01921400
The ClinicalTrials.gov registry entry for NCT01921400 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01921400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01921400 about?
NCT01921400 is a clinical study titled "The Pathogenesis of Hepatitis C Virus Vertical Transmission". To evaluate for the presence of HCV Core protein, HCV RNA and SPP in the placenta and fetal membranes using paraffin-embedded sections and post-delivery specimens respectively. In parallel, we will assess placental tissue for evidence of HCV infection using a novel in situ hybridization technique an...
What is the current status of trial NCT01921400?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2013-01. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT01921400?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.